Ciclopirox Olamine Cream USP
Reason Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
1,709 recalls · Class III, newest first
Reason Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.
Reason Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Reason Failed Impurities/Degradation Specifications
Reason Subpotent Drug
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Reason Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.
Reason Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.
Reason Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.
Reason Marked Without An Approved NDA/ANDA: FDA analysis found this product to contain diethyl phthalate, an inactive ingredient in several modified release solid oral dosage forms, making this product unapproved drug for which safety and efficacy have not been establish and therefore, subject to recall.
Reason Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.
Reason CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.
Reason Presence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mg
Reason Chemical Contamination
Reason Labeling: Incorrect/Undeclared Excipients: Firm is recalling A+D Diaper Rash Cream due to a labeling claim issue.
Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.
Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.
Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.